Completed
Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A
NCT01401257
- Conditions
- Charcot-Marie-Tooth Disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
- Locations
-
- Hôpital Roger Salengro Lille, France
- CHU Dupuytren Limoges, France
- CHU Lyon Sud Lyon, France
- Hôpital La Timone Marseille, France